SCHEMBL18816144

SCHEMBL18816144

O=[N+]([O-])c1cccc(C(F)(F)F)c1C=CN1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
ENPP2 Q13822 1/20 0.42
MAPK1 P28482 2/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
SIRT6 Q8N6T7 1/20 0.38
HTT P42858 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CTSB P07858 1/20 0.37
AR P10275 1/20 0.37
APP P05067 1/20 0.37
ATM Q13315 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18816129 0.99 ALDH1A1 (0.44) ALDH1A1ENPP2MAPK1NPC1MAPT
SCHEMBL28103733 0.90 ATM (0.45) ALDH1A1ENPP2MAPTTDP1KMT2A
SCHEMBL14185148 0.85 ALDH1A1 (0.50) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL1126961 0.82 ALDH1A1 (0.48) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL1126964 0.82 ALDH1A1 (0.48) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL18816151 0.79 HSD17B10 (0.50) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL18842342 0.79 HSD17B10 (0.50) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL18816134 0.78 HSD17B10 (0.49) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL8968649 0.77 ALDH1A1 (0.53) ALDH1A1MAPK1NPC1MAPTRAB9A
SCHEMBL8968657 0.77 ALDH1A1 (0.53) ALDH1A1MAPK1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106232572-B The manufacturing method of nitro compound 住友化学株式会社 2018-11-13 CN disclosed
US-9975844-B2 Method for producing nitro compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-22 US disclosed
CN-106164041-B The manufacture method of nitro compound 住友化学株式会社 2018-05-04 CN disclosed
US-9822061-B2 Method for producing nitro compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-21 US disclosed
US-20170144961-A1 METHOD FOR PRODUCING NITRO COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
US-20170129846-A1 METHOD FOR PRODUCING NITRO COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-11 US disclosed
CN-106232572-A The manufacture method of nitro compound 住友化学株式会社 2016-12-14 CN disclosed
CN-106164041-A The manufacture method of nitro compound 住友化学株式会社 2016-11-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170144961-A1 METHOD FOR PRODUCING NITRO COMPOUND NOS2, CYP11B2, NOS1 ALDH1A1 345/4885ENPP2 3047/4885MAPK1 636/4885
US-20170129846-A1 METHOD FOR PRODUCING NITRO COMPOUND NOX1, NOS1, NOX3 ALDH1A1 451/4885ENPP2 4488/4885MAPK1 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.